Incyte News, Incyte Quote, INCY Quote

Incyte (NQ:INCY) Delayed: 108.53 +4.13 (3.96%)

Prev. Close

$104.40

Today 6M 1Y 5Y

Open

$105.53

52 Wk High

$118.49

52 Wk Low

$55.00

Day High

$109.10

Day Low

$104.49

P/E

N/A

EPS

$-0.56

Volume

1,178,158

Friends, Peers and Foes (?): LLY, MIRM, GUD, ASND, PFE (more...)

ALERTS | RSS

Jun 24, 2026 06:43 AM H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
Jun 22, 2026 01:25 PM Incyte (INCY) PT Raised to $105 at Truist Securities
Jun 22, 2026 07:53 AM Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules
Jun 22, 2026 07:01 AM Form 8-K INCYTE CORP For: Jun 22
Jun 22, 2026 04:19 AM BMO Capital Upgrades Incyte (INCY) to Market Perform
Jun 19, 2026 02:01 AM Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Jun 15, 2026 10:10 AM BMO Capital on Incyte (INCY): ''989 Updates Provide More Context to ET/MF Opportunity'
Jun 15, 2026 09:24 AM Stifel Reiterates Buy Rating on Incyte (INCY)
Jun 14, 2026 04:35 PM Mirum and Incyte report positive phase 2 results for FOP treatment
Jun 14, 2026 04:35 PM Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva

Entities mentioned with INCY

View All Entities